Revolution in the drug discovery process in the biotechnology market
Sylwia Ziemacka talks to Janusz Homa, CEO & Co-Founder of Ardigen S.A. What is Ardigen’s profile? What exactly do you do? A significant problem in modern pharmaceuticals and biotechnology is the growing cost of discovering and bringing a new drug to market – estimated at $2.6 billion. Conversely, there are many unmet clinical needs that…